Global shortage of Ozempic (semaglutide) and Trulicity (dulaglutide).

The Therapeutic Goods Administration (TGA) is working with pharmaceuticals and medical organisations to reduce the impact of the global shortage of the two diabetic medicines: Ozempic (semaglutide) and Trulicity (dulaglutide).

NB: There will be no further supplies of Ozempic available in Australia and access to Trulicity is expected to be very limited until the end of March 2023.

Please help disseminate this information out to patients to allow time to access alternative treatments. TGA has published two webpages (links below) providing practical information and advice about these shortages including a link to new clinical guidelines from RACGP:

Ozempic (semaglutide) shortage web page
Trulicity (dulaglutide) shortage web page

If you have any questions, please contact the Medicine Shortages Section on +612 6289 4646 [email protected].

RACP 2023 CPD Framework | Note: Important Changes

Please note the important changes to the CPD activities physicians will need to complete from 1 January 2023, as directed by the Medical Board of Australia and Medical Council of New Zealand (MCNZ) | Te Kaunihera Rata o Aotearoa.

WATCH THE VIDEO (right) as Prof Martin Veysey, Chair of the RACP’s CPD Committee, explains the changes. 

READ MORE about the new requirements on the RACP website and find CPD resources and templates in the MyCPD Interactive Handbook.

JOIN THE WEBINAR: 2023 MyCPD Framework with Q&A on Tuesday 22 November 2022. Discuss the upcoming changes and what they mean for you. Time: 5pm – 6pm AEDT / 7pm – 8pm NZDT. Register now.

If you have any queries or would like to contribute to the developing the College’s resources, then email the relevant location here.  [email protected]  /  [email protected] 

New CSANZ and HLC Appointments

Following the recent resignations of Dr Paul Bridgman as Chair of the Education Committee and Prof Stephen Duffy as Honorary Secretary, CSANZ Members are advised the following appointments to these roles.

Prof Jenny Deague (WA) has been appointed by the Board as Chair of the Education Committee and Dr Mayanna Lund (NZ) has been appointed CSANZ Honorary Secretary.

A/Prof Salvatore Pepe has been appointed in-coming Editor-in-Chief of Heart Lung and Circulation. A/Prof Pepe will take over the role at the conclusion of Prof Robert Denniss’ term at the end of 2023.  Prof Denniss will stay on the Board until the November, 2022 Board meeting and a special ceremony will be held at the 2023 AGM to acknowledge Prof Denniss’ service and achievements as HLC Editor-in-Chief.

New MBS Items from 1 November 2022

Two new MBS items (11736 and 11737) will be introduced for remote monitoring of cardiac ILR devices. These new services will be remote mirror services of current in rooms service MBS items 11728 and 11731, allowing remote services to be performed.  Refer to the Quick Reference Guide for further details now available on MBS Online.

In addition, 8 eight MBS items for cardiothoracic surgery items 38510, 38513, 38516, 38517, 38555, 38556, 38557 and 38572 will be amended to incentivise the use of advanced techniques and procedures. See full details of these changes on the MBS website.

Claiming Guide for repeat MBS services for stress echo and stress MPS

In response to a number of queries regarding claiming of repeat MBS services for stress echo (item 55143) and stress MPS (items 61349, 61410), the MBS has produced a claiming guide to assist providers.  Link to MBS claiming guide 

Note that there are no changes to the requirements of the services for stress echocardiography and stress MPS, including the qualifying indications, time dependencies or item associations that currently exist.

SURVEY | use of mHealth applications in clinical practice – Cardiovascular Nurses

You are invited to participate in a study being led by the University of Wollongong (UOW) about the use of m-Health applications in clinical practice. The survey is anonymous and takes approximately 10-15 minutes complete.

Wa’ed Shiyab (PhD candidate at UOW) is conducting the survey to examine the use of mHealth applications by nurses for chronic conditions and lifestyle risk factors.

You can access the survey by scanning the QR code or via this link https://redcap.link/mHealthnurse

Study investigators include:  Wa’ed Shiyab (PhD candidate) and Prof Liz Halcomb (Primary Supervisor). Dr Kaye Rolls and A/Prof Caleb Ferguson (Co-Supervisors).

If you have any questions, please contact Mrs Wa’ed Shiyab via email or Prof Liz Halcomb email or phone 4221 3784.

Interviews with 2022 CSANZ ASM Prize Winners

The Education Committee invited the following prize winners to be interviewed after the 2022 CSANZ ASM to talk about their winning work that was presented, and what the future looks like for this project and their work. 

2022 Ralph Reader in Basic and Translational Science Prize Winner
2022 Ralph Reader in Clinical Science Prize Winner
2022 Cardiovascular Nursing Prize Winner
2022 Allied Health, Science & Technology Prize Winner
Dr Dinesh Selvakumar Westmead Institute for Medical Research

Abstract: Cellular Heterogeneity in Human Pluripotent Stem Cell Derived Cardiomyocyte Grafts are responsible for Arrhythmias and are Treatable with Pharmacotherapy and Catheter Ablation.

Read abstract in full here as published in the HLC Journal.

Dr Julia Isbister 
Centenary Institute

Abstract: “Concealed Cardiomyopathy” is an Important Cause of Autopsy-Inconclusive Sudden Cardiac Death and Diagnosis Impacts Care of Surviving Relatives

Read article in full here as published in the HLC Journal.

Kristel Janssens
Baker Heart and Diabetes Institute

Abstract: Modest association between peak exercise blood pressure and ambulatory hypertension in endurance athletes.

Read abstract in full as published in HLC Journal.

Adam Livori
Ballarat Health Services

Abstract: Assessment of Telehealth Cardiology Pharmacist Clinic in Improving Therapy Adherence following Acute Coronary Syndrome and PCI.

  Read abstract in full as published in HLC Journal.

Posts navigation